Search Login Register

Leukoaraiosis Summary

Description: Non-specific white matter changes in the BRAIN, often seen after age 65. Changes include loss of AXONS; MYELIN pallor, GLIOSIS, loss of ependymal cells, and enlarged perivascular spaces. Leukoaraiosis is a risk factor for DEMENTIA and CEREBROVASCULAR DISORDERS.

Also Known As: Leukoaraioses

Networked: 185 relevant articles (2 outcomes, 28 trials/studies) for this Disease

Key Drugs and Agents for Leukoaraiosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Blood Glucose (Blood Sugar) : 1 outcome in 2 results : IBA
  2. Arginine (L-Arginine) : 1 outcome in 1 result : FDA 19
  3. glucuronyl glucosamine glycan sulfate (Vessel) : 5 studies in 63 results : IBA
  4. Homocysteine : 2 studies in 9 results : IBA
  5. Biological Markers (Surrogate Marker) : 2 studies in 6 results : IBA
  6. DNA (Deoxyribonucleic Acid) : 2 studies in 4 results : IBA
  7. Nimodipine (Modus) : 2 studies in 2 results : FDA 4 Generic
  8. Anticoagulants : 1 study in 4 results : IBA
  9. Tissue Plasminogen Activator (Alteplase) : 1 study in 3 results : FDA 2
  10. Protons (Proton) : 1 study in 2 results : IBA
Show All >>

Diseases Related to Leukoaraiosis

  1. Stroke (Strokes)
  2. Dementia (Dementias)
  3. Edema
  4. Hypertension (High Blood Pressure)
  5. Brain Infarction
Show All >>

Key Therapies for Leukoaraiosis

Efficacy Chart >>
  1. Carotid Endarterectomy : 1 study in 4 results
  2. Activities of Daily Living (ADL) : 1 study in 3 results
  3. Denervation : 1 study in 2 results
  4. Thrombectomy : 1 study in 1 result
  5. Thrombolytic Therapy : 1 study in 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.